Monopar Therapeutics Stock Forecast - Accumulation Distribution
| MNPR Stock | USD 70.29 1.12 1.57% |
Monopar Stock outlook is based on your current time horizon. Although Monopar Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Monopar Therapeutics' systematic risk associated with finding meaningful patterns of Monopar Therapeutics fundamentals over time.
As of today, the RSI of Monopar Therapeutics' share price is approaching 47. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Monopar Therapeutics, making its price go up or down. Momentum 47
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.47) | EPS Estimate Current Year (1.67) | EPS Estimate Next Year (3.48) | Wall Street Target Price 112 | EPS Estimate Current Quarter (0.43) |
Using Monopar Therapeutics hype-based prediction, you can estimate the value of Monopar Therapeutics from the perspective of Monopar Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Monopar Therapeutics after-hype prediction price | USD 70.62 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Monopar Therapeutics to cross-verify your projections. Monopar Therapeutics Additional Predictive Modules
Most predictive techniques to examine Monopar price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Monopar using various technical indicators. When you analyze Monopar charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 26225.58 | 16954.22 |
| Check Monopar Therapeutics Volatility | Backtest Monopar Therapeutics | Information Ratio |
Monopar Therapeutics Trading Date Momentum
| On January 27 2026 Monopar Therapeutics was traded for 70.29 at the closing time. The top price for the day was 72.70 and the lowest listed price was 67.89 . The trading volume for the day was 256.3 K. The trading history from January 27, 2026 did not cause price change. The trading delta at closing time against the current closing price is 1.54% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Monopar Therapeutics to competition |
Other Forecasting Options for Monopar Therapeutics
For every potential investor in Monopar, whether a beginner or expert, Monopar Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Monopar Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Monopar. Basic forecasting techniques help filter out the noise by identifying Monopar Therapeutics' price trends.Monopar Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Monopar Therapeutics stock to make a market-neutral strategy. Peer analysis of Monopar Therapeutics could also be used in its relative valuation, which is a method of valuing Monopar Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Monopar Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Monopar Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Monopar Therapeutics shares will generate the highest return on investment. By undertsting and applying Monopar Therapeutics stock market strength indicators, traders can identify Monopar Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 16954.22 | |||
| Daily Balance Of Power | (0.23) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 70.3 | |||
| Day Typical Price | 70.29 | |||
| Price Action Indicator | (0.56) | |||
| Period Momentum Indicator | (1.12) | |||
| Relative Strength Index | 47.58 |
Monopar Therapeutics Risk Indicators
The analysis of Monopar Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Monopar Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting monopar stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.66 | |||
| Standard Deviation | 3.55 | |||
| Variance | 12.63 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Monopar Therapeutics
The number of cover stories for Monopar Therapeutics depends on current market conditions and Monopar Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Monopar Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Monopar Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Monopar Therapeutics Short Properties
Monopar Therapeutics' future price predictability will typically decrease when Monopar Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Monopar Therapeutics often depends not only on the future outlook of the potential Monopar Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Monopar Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.5 M | |
| Cash And Short Term Investments | 60.2 M |
Additional Tools for Monopar Stock Analysis
When running Monopar Therapeutics' price analysis, check to measure Monopar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Monopar Therapeutics is operating at the current time. Most of Monopar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Monopar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Monopar Therapeutics' price. Additionally, you may evaluate how the addition of Monopar Therapeutics to your portfolios can decrease your overall portfolio volatility.